Cathie's Ark Logo
Twist Bioscience Corp Logo

ARKK Holdings of Twist Bioscience (TWST) - Updated Daily

GenomicsSynthetic BiologyWorkflow Automation
Date
Direction
Shares
Fund Weight
Fund
March 28, 2023
BUY126.757k0.0264%ARKK
March 7, 2023
BUY36.375k0.0089%ARKK
February 6, 2023
BUY49.263k0.0142%ARKK
December 19, 2022
BUY4.611k0.0016%ARKK
December 16, 2022
BUY3.385k0.0012%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
0.75%$859.70m
🏋🏿‍♂️Weight Rank In ARKK🌏Country
23🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
24$55.60
🎫ARK Ownership Percent
6.54%
Description
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by 'writing' DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
Website
www.twistbioscience.com

Other ETFs That Hold TWST

Ticker
NameWeight
ARKGARK Genomic Revolution ETF2.59%
ARKKARK Innovation ETF0.88%
XBISPDR® S&P Biotech ETF0.71%

Research Notes and Commentary for TWST